Stryker Rejuvenate & ABG II Modular Hip Implants
Defective Hip Implant Attorneys in Buffalo
Stryker Corporation's Rejuvenate modular hip implant was approved for sale in the United States by the Food and Drug Administration (FDA) on June 3, 2008 and the ABG II was approved on November 4, 2009 as an extension of the Stryker Modular Hip approved in 2007. According to Stryker's marketing materials, the purported benefits of the ABG II and Rejuvenate hips were enhanced stability, intra-operative flexibility, and the ability to customize the hip to match a patient's anatomy. Both the Rejuvenate and the ABG II were approved through a process that did not require pre-market clinical trials.
Were you or a loved one negatively affected by Stryker’s Rejuvenate or ABG II hip implants? The Buffalo defective hip implant attorneys at Faraci Lange, LLP can help you determine whether you have grounds for a claim. We are currently representing clients in litigation involving defective Stryker Rejuvenate and ABG II Modular Hip Implants.
Problems Associated with the Stryker Rejuvenate & ABG II Modular Hip Implants
It did not take long before Stryker and the FDA began receiving reports of problems in patients with these hip implants. Due to the dual modular design, the modular junctions of the hip experienced fretting and corrosion that lead to excessive amounts of metal debris being shed from the implant into the area around the hip.
The excessive metal debris in and around the hip joint leads to complications, such as:
- Fluid effusions
- Metal ions in the blood stream
- Loosening of the implant
These problems can and frequently do lead to revision surgery many years earlier than anticipated.
Stryker Hip Implant Recall
In April 2012, Stryker issued an Urgent Field Safety Notice to surgeons and hospitals regarding the Rejuvenate and ABG II devices. In the notice, Stryker states that it had received reports of device failure due to metal debris contamination and refers to problems with fretting and corrosion. Stryker also states that patients had problems with tissues necrosis, metallosis, adverse soft tissue reaction, and pseudotumor formation. Just three months after issuing the Urgent Field Safety Notice, Stryker issued a voluntary recall of all ABG II and Rejuvenate hips in the United States.
In addition, Stryker issued guidance to surgeons who had implanted the Rejuvenate and ABG II hips on how to monitor their patients for problems. Stryker recommended surgeons consider clinical examination, such as bloodwork and cross-section imaging, regardless of whether a patient is experiencing pain or swelling. Stryker also recommends repeat follow-up examination even if there were no problems discovered at the initial exam.
Contact Faraci Lange, LLP for a Free Consultation
If you received a Stryker Rejuvenate or ABG II hip implant and you have experienced problems, you could be entitled to financial compensation for your additional medical bills, lost wages, pain and suffering, and other economic and non-economic damages. We invite you to contact our Buffalo defective medical device attorneys for help in Rochester and all of the surrounding areas.
Call us at (888) 997-4110 today.
“When my frustrations with the process were heightened, my representative calmly explained how this type of litigation usually proceeds.”- Phil N.
“Kristin always kept us updated and advised us as to what our next steps should be.”- Dick K.